Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris J Packard

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Atherosclerosis|November 3, 2015
Reflections on a pioneer in the field of diet, lipids and vascular diseaseChris J Packard
Current Opinion in Lipidology|July 13, 2006
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular diseaseChris J Packard
Current Opinion in Cardiology|May 7, 2009
Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic targetChris J Packard
Expert Review of Clinical Pharmacology|November 25, 2011
Optimizing lipid-lowering therapy in the prevention of coronary heart diseaseChris J Packard
Circulation|November 16, 2020
Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial"Chris J Packard
Current Opinion in Lipidology|October 15, 2019
Strategies to alter the trajectory of atherosclerotic cardiovascular diseaseChris J Packard
Current Atherosclerosis Reports|February 17, 2022
Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular DiseaseChris J Packard
Circulation|January 25, 2017
Unpacking and Understanding the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Apolipoprotein B MetabolismChris J Packard
European Heart Journal|November 17, 2019
Triglyceride lowering 2.0: back to the future?Chris J Packard
Trends in Cardiovascular Medicine|January 17, 2018
LDL cholesterol: How low to go?Chris J Packard
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Atherosclerosis|November 3, 2015
Reflections on a pioneer in the field of diet, lipids and vascular diseaseChris J Packard
Current Opinion in Lipidology|July 13, 2006
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular diseaseChris J Packard
Current Opinion in Cardiology|May 7, 2009
Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic targetChris J Packard
Expert Review of Clinical Pharmacology|November 25, 2011
Optimizing lipid-lowering therapy in the prevention of coronary heart diseaseChris J Packard
Circulation|November 16, 2020
Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial"Chris J Packard
Current Opinion in Lipidology|October 15, 2019
Strategies to alter the trajectory of atherosclerotic cardiovascular diseaseChris J Packard
Current Atherosclerosis Reports|February 17, 2022
Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular DiseaseChris J Packard
Circulation|January 25, 2017
Unpacking and Understanding the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Apolipoprotein B MetabolismChris J Packard
European Heart Journal|November 17, 2019
Triglyceride lowering 2.0: back to the future?Chris J Packard
Trends in Cardiovascular Medicine|January 17, 2018
LDL cholesterol: How low to go?Chris J Packard
Pageof 15